Prospective Diagnostic Accuracy Study Comparing CT and MRI (VI-RADS) for Local Staging of Newly Diagnosed Bladder Cancer
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years
• Newly diagnosed bladder cancer on cystoscopy
• Planned TURBT or cystectomy within 6 weeks
• Eligible for both CT and MRI within 6 weeks
• Written informed consent provided
Locations
Other Locations
Norway
Oslo University Hospital
RECRUITING
Oslo
Contact Information
Primary
Study Coordinator, Department of Urology
postmottak@ous-hf.no
+47 22 89 40 00
Time Frame
Start Date: 2026-04-22
Estimated Completion Date: 2028-10-31
Participants
Target number of participants: 150
Treatments
Imaging Comparison Group
All participants undergo contrast-enhanced CT and multiparametric MRI (VI-RADS) as part of routine diagnostic work-up prior to transurethral resection of the bladder tumor or cystectomy. Imaging findings are compared with histopathology for assessment of diagnostic accuracy.
Related Therapeutic Areas
Sponsors
Leads: Oslo University Hospital